Who owns NOVABAY PHARMACEUTICALS INC?
- CUSIP Number: 66987p300
Tip: Access positions for across all investors
Analyze quarterly positions in Novabay Pharmaceuticals with up to 7 years of data, all consolidated into one spreadsheet
Download as csv
Download as Excel
Top investors of Novabay Pharmaceuticals stock
Who bought or sold NOVABAY PHARMACEUTICALS INC this quarter?
| Fund or Company Name | Shares Held | Valued At | Change in Shares | As Of | Actions |
|---|---|---|---|---|---|
| UBS Group | 221k | $23k | 2496% | Mar 2024 |
|
| Ronald Blue Trust | 37.00 | $3.999700 | 0% | Jun 2024 |
|
| Advisor Group Holdings | 37.00 | $3.999700 | 0% | Mar 2024 |
|
Who sold out of Novabay Pharmaceuticals?
| Fund or Company Name | Date Sold | Shares Held | Valued At |
|---|---|---|---|
| Two Sigma Securities | Mar 2024 | 149k | $16k |
| Geode Capital Management | Mar 2024 | 25k | $2.6k |
| Tower Research Capital | Mar 2024 | 15k | $1.6k |
| Vanguard Group | Mar 2024 | 14k | $1.4k |
| Zacks Investment Management | Mar 2024 | 10k | $1.0k |
| Morgan Stanley | Mar 2024 | 158.00 | $17.000800 |
| Bank of America Corporation | Mar 2024 | 86.00 | $9.004200 |
| Wells Fargo & Company | Mar 2024 | 51.00 | $4.998000 |